DT
HealthMore in Health→
Early liver transplant trial hints at a future with less lifelong immunosuppression
Key Takeaways
- Researchers infused donor-derived immune cells before living donor liver transplantation.
- Some recipients have stayed off immunosuppressive drugs for more than three years.
- The early trial supports larger studies aimed at transplant tolerance.
DE
DT Editorial Team··via medicalxpress.com